[to top of second column]
Some doctors thought the device's price -- it sells for approximately $30,000 to $40,000, not including the cost of implantation -- would be a major stumbling block to its acceptance. Patients with mild heart failure, who were not experiencing any painful symptoms, might also be reluctant to have surgery to get the device.
Clyde Yancy, president of the American Heart Association called it an "incremental (improvement), not a breakthrough." Yancy was not linked to the research.
Others agreed the study wouldn't immediately affect how heart failure patients are treated.
"Previous devices have shown us that it takes time to consider benefits for real-world populations," said Alfred Bove, president of the American College of Cardiology in a statement. "Even if costs were not a factor, we still do not have enough information to expand treatment right away."
On the Net:
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
< Recent articles
Back to top
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Law & Courts |
Spiritual Life |
Health & Fitness |
Calendar | Letters to the Editor